Home > Our work > Responsible AI > AI for public-domain drug discovery
AI for public-domain drug discovery
This project responds to international demand from governments to find ways to accelerate drug discovery more broadly, by providing a set of recommendations for GPAI member countries and the international community to create an enabling environment for open AI research towards the development of new drugs or the repurposing of existing ones to address public health challenges.
